Microbiological study of neonatal conjunctivitis with special reference to Chlamydia trachomatis

Indian J Ophthalmol. 2002 Dec;50(4):295-9.

Abstract

Purpose: To study the microbial agents, chiefly Chlamydia trachomatis and other bacteria, in neonatal conjunctivitis.

Methods: Conjunctival specimens from 70 newborns with conjunctivitis were subjected to bacterial culture and sensitivity testing, monoclonal antibody based C. trachomatis antigen detection test and species-specific Chlamydia antibody detection in the sera of babies and their mothers, by micro-immunofluorescence assay.

Results: Bacteria were isolated from 35 (50%) babies; the majority (20, 57.14%) were Staphylococcus epidermidis. C. trachomatis antigen was detected in conjunctival smears of 17 (24%) babies, and 6 (35.29%) of them were positive for other bacteria. Six babies and their mothers tested positive for C. trachomatis Ig G antibodies. At follow-up after 14 weeks, 6 (35.29%) of the Chlamydia antigen-positive babies were found to have developed recurrent conjunctivitis.

Conclusion: C. trachomatis is responsible for almost a quarter of all cases of neonatal conjunctivitis, with recurrences in 35% of cases. Bacteria could be isolated from 50% of the patients though the exact role of Staphylococcus epidermidis, isolated from 28.65% of the neonatal conjunctivitis cases, remains unclear.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Bacterial / blood
  • Antigens, Bacterial / analysis
  • Chlamydia Infections / drug therapy
  • Chlamydia Infections / microbiology*
  • Chlamydia Infections / pathology
  • Chlamydia trachomatis / immunology
  • Chlamydia trachomatis / isolation & purification*
  • Conjunctiva / microbiology*
  • Delivery, Obstetric
  • Female
  • Fluorescent Antibody Technique, Direct
  • Humans
  • Infant, Newborn
  • Male
  • Microbial Sensitivity Tests
  • Ophthalmia Neonatorum / drug therapy
  • Ophthalmia Neonatorum / microbiology*
  • Ophthalmia Neonatorum / pathology
  • Ophthalmic Solutions / therapeutic use
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Ophthalmic Solutions